BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ideon - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ideon
X-ORIGINAL-URL:https://ideon.se
X-WR-CALDESC:Events for ideon
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20231109T180000
DTEND;TZID=Europe/Stockholm:20231109T190000
DTSTAMP:20260526T093905
CREATED:20231108T133555Z
LAST-MODIFIED:20240718T214424Z
UID:374752-1699552800-1699556400@ideon.se
SUMMARY:Crowd Funding Webinar: Meet the Team Behind the Invention
DESCRIPTION:The global population is aging\, leading to a rise in degenerative diseases.Preventative care is the only solution\, says Diego Guenot\, founder. Access to early diagnosis is vital\, but current methods are invasive and costly.Alzheimer’s affects millions across the globe\, it cost $300B in the USA alone in 2020. Degenerative retinal diseases affect 300M people worldwide. This costs society $255B.Mantis-Photonics’ patented solution requires no needles or radiation to deliver information on your eye-\, brain-\, and cardiovascular issues. \nThe Eye is a Window to Your Health\nThe retina is the only observable part of the central nervous system\, and it is the only place where you can observe blood vessels directly. \nOur patented hyperspectral technology allows to scan the retina instantly in 36 colors instead of the 3 primary colors of conventional cameras. This wealth of information allows us to accurately determine the chemical composition of the retina and detect abnormalities caused by diseases more accurately and earlier than standard imaging. \nLearn more about investing in Manti’s solution and meet the team behind the innovation:What: Webinar – Meet the team behind the innovationWhen: 9 Nov 2023 @ 6-7 PM \nSIGN UP FOR THE WEBINAR HERE\nWhy invest?\n\nMantis Photonics: ‘We believe that we can enter this market by 2025 with our unique solution’.\nThe technology is proven. Mantis Photonics cameras are tested in two ongoing clinical trials. We presented the first results on ocular oncology in October at the yearly congres of retinal specialists in Amsterdam.\nYour investment will enable the team to advance the development of our device\, conduct clinical trials\, start the regulatory approvals process\, and gather commercial traction.\nMantis Photonics has an ambitious development plan\, where ‘we make our technology accessible to more clients by automating and industrializing the design’.\nMantis Photonics is founded by a strong team of engineers: The team’s expertise in physics\, engineering\, product design\, and entrepreneurship allows the founders to develop the technology and the company.\nMantis Photonics has an active board of directors: This group of highly accomplished professionals with expertise in management\, business\, ophthalmology\, and regulatory affairs supports the founders’ team in their journeyRead moreTHEIR BIG IDEA: ‘The eyes\, chico\, they never lie’ | Ideon Science Park
URL:https://ideon.se/event/crowd-funding-webinar-meet-the-team-behind-the-invention/
CATEGORIES:Seminar,Webinar
ATTACH;FMTTYPE=image/jpeg:https://ideon.se/wp-content/uploads/2024/07/eye2-e1698758895982.jpg
END:VEVENT
END:VCALENDAR